Oscar Health Inc. (OSCR) Misses Q1 EPS by 12c; reaffirms guidance

Oscar Health Inc. (NYSE: OSCR) reported Q1 EPS of ($0.18), $0.12 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.27 billion.

Oscar is reaffirming its full year 2023 outlook across all metrics as provided in its financial results press release dated February 9, 2023, including anticipated MLR range between 82% and 84%, and Adjusted EBITDA1 loss of ($175) million to ($75) million.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs